Supreme Court asked to restore access to mail-order abortion pill
Summary
A drug company has asked the U.S. Supreme Court to stop a lower court’s order that blocks sending the abortion pill mifepristone by mail. The lower court’s ruling temporarily reverses FDA rules that made it easier to get the pill by mail, causing confusion for patients and providers while the legal case continues.Key Facts
- An appeals court blocked the distribution of the abortion pill mifepristone by mail on Friday.
- Danco Laboratories, the drug maker, asked the Supreme Court for emergency relief to restore mail-order access.
- The lower court’s order reverses 2023 FDA guidelines from the Biden administration that had eased access to the pill.
- The Supreme Court had rejected a similar legal challenge two years ago, saying the challengers did not have the right to sue.
- The new legal challenge was brought by the state of Louisiana, which argues it should be allowed to sue.
- Danco Laboratories says the ruling causes confusion and harm for patients, pharmacies, and doctors.
- The Supreme Court may quickly decide whether to keep the order or allow mail-order dispensing to continue.
- Louisiana’s Attorney General supports defending the court’s order to restrict the pill’s distribution.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.